We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
SAVA

Price
3.28
Stock movement down
-0.14 (-4.09%)
Company name
Cassava Sciences Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
158.45M
Ent value
66.59M
Price/Sales
67.48
Price/Book
0.95
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
30.45%
1 year return
-87.73%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-10-30

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

SAVA does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales67.48
Price to Book0.95
EV to Sales28.36

FINANCIALS

Per share

Loading...
Per share data
Current share count48.31M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)-1.16

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash112.38M
Net receivables835.00K
Total current assets114.82M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment24.23M
Total assets135.38M
Accounts payable42.82M
Short/Current long term debt0.00
Total current liabilities47.33M
Total liabilities47.41M
Shareholder's equity0.00
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open3.36
Daily high3.51
Daily low3.27
Daily Volume879K
All-time high161.00
1y analyst estimate8.00
Beta-1.09
EPS (TTM)-
Dividend per share0.00
Ex-div date13 Dec 2012
Next earnings date13 Nov 2025

Downside potential

Loading...
Downside potential data
SAVAS&P500
Current price drop from All-time high-97.96%-1.10%
Highest price drop-99.26%-19.00%
Date of highest drop10 Apr 20258 Apr 2025
Avg drop from high-96.60%-2.76%
Avg time to new high-5 days
Max time to new high266 days89 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
SAVA (Cassava Sciences Inc) company logo
Marketcap
158.45M
Marketcap category
Small-cap
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. Cassava Sciences, Inc. was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.
Employees
30
Investor relations
-
SEC filings
CEO
Remi Barbier
Country
USA
City
Austin
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...